Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Liabilities and Shareholders Equity: 2016-2021

Historic Liabilities and Shareholders Equity for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $15.3 million.

  • ENDRA Life Sciences' Liabilities and Shareholders Equity rose 185.65% to $15.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $60.2 million, marking a year-over-year increase of 204.16%. This contributed to the annual value of $8.8 million for FY2020, which is 22.14% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Liabilities and Shareholders Equity of $15.3 million as of Q3 2021, which was down 11.18% from $17.2 million recorded in Q2 2021.
  • Over the past 5 years, ENDRA Life Sciences' Liabilities and Shareholders Equity peaked at $18.9 million during Q1 2021, and registered a low of $545,126 during Q1 2017.
  • Its 3-year average for Liabilities and Shareholders Equity is $8.3 million, with a median of $5.4 million in 2020.
  • As far as peak fluctuations go, ENDRA Life Sciences' Liabilities and Shareholders Equity soared by 1,147.80% in 2017, and later crashed by 82.73% in 2018.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Liabilities and Shareholders Equity stood at $6.1 million in 2017, then increased by 17.95% to $7.2 million in 2018, then declined by 0.64% to $7.2 million in 2019, then increased by 22.14% to $8.8 million in 2020, then spiked by 185.65% to $15.3 million in 2021.
  • Its Liabilities and Shareholders Equity was $15.3 million in Q3 2021, compared to $17.2 million in Q2 2021 and $18.9 million in Q1 2021.